synthetic glp 1 Glucagon-like peptide-1 receptor: mechanisms and advances in therapy enhancing digestion and overall comfort GLP1 for Weight Loss For

1/Winter 2023

Journal of Pharmacy Technology

7.4.4 Next-generation agonists The development of dual GLP-1/GIP receptor agonists (e.g., tirzepatide) and novel blood-brain barrier-penetrant formulations may offer superior neuroprotective efficacy by more potently engaging central receptors or providing a broader spectrum of action ( 7.5 Limitations of current evidence Several limitations must be considered when interpreting the current evidence

[PMID: 31976029] PubMed record related to this compound for laboratory literature review

An expression cloning method was used to identify genes in human cancer cells that complement the loss of GPX4